To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SGEFTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
169 supporting clones for gene SGEF back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AK127282 hippocampus SGEF.a 1 to 3974 2 to 3975 V29L L60S L461M W773S tiling clone, available from FLJ,   3975/3975
(100 %)
10 diff
(99.8 %id)
DA319306 hippocampus SGEF.a 1 to 565 2 to 566   capped   565/565
(100 %)
4 diff
(99.3 %id)
DB309002 hippocampus SGEF.a 3488 to 3974 487 to 1       487/487
(100 %)
2 diff
(99.6 %id)
DA334208 hippocampus SGEF.b -9 to 510 2 to 521   capped   520/520
(100 %)
4 diff
(99.3 %id)
DB069290 testis SGEF.b 1 to 553 2 to 554   tiling clone, capped   553/553
(100 %)
1 diff
(99.9 %id)
CB959784 Human Placenta, placenta SGEF.b 3 to 717 24 to 747       724/755
(95 %)
14 diff
(98.2 %id)
CB990187 Human Placenta, placenta SGEF.b 3 to 487 24 to 521       498/910
(54 %)
28 diff
(97.0 %id)
AF415175 prostate cancer SGEF.b 15 to 3871 1 to 3857 V29L L60S S781R tiling clone,   3857/3857
(100 %)
9 diff
(99.8 %id)
BG037060 testis SGEF.b 23 to 563 1 to 538       538/538
(100 %)
8 diff
(98.6 %id)
DA220091 brain SGEF.b 27 to 591 2 to 567   capped   566/566
(100 %)
4 diff
(99.3 %id)
DA742228   SGEF.b 27 to 590 2 to 566   capped   565/566
(99 %)
5 diff
(99.2 %id)
BC078655 testis SGEF.b 29 to 3871 1 to 3843 V29L L60S S707T tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 3843/3843
(100 %)
7 diff
(99.9 %id)
DA318197 hippocampus SGEF.b 30 to 559 2 to 534   capped   533/533
(100 %)
3 diff
(99.5 %id)
DA441801 tongue, tumor tissue SGEF.b 41 to 592 2 to 554   capped   553/553
(100 %)
4 diff
(99.3 %id)
DB285318 uterus SGEF.b 45 to 580 2 to 537   capped   536/536
(100 %)
4 diff
(99.3 %id)
DA756611   SGEF.b 46 to 609 2 to 566   capped   565/565
(100 %)
4 diff
(99.3 %id)
BP249869 hippocampus SGEF.b 48 to 633 1 to 587       587/587
(100 %)
4 diff
(99.4 %id)
BJ993725.
matches multiple genes
hepatoblastoma SGEF.b 50 to 600 1 to 551     also hits gene TUBE1 551/551
(100 %)
3 diff
(99.5 %id)
DB235831 trachea SGEF.b 57 to 600 2 to 545   capped   544/544
(100 %)
3 diff
(99.5 %id)
CD109362 Human Placenta, placenta SGEF.b 61 to 577 28 to 545       518/770
(67 %)
21 diff
(97.3 %id)
CD109477 Human Placenta, placenta SGEF.b 61 to 743 28 to 730       703/808
(87 %)
36 diff
(95.6 %id)
DB454635 testis SGEF.b 73 to 554 1 to 482       482/482
(100 %)
4 diff
(99.2 %id)
DA095631 cerebellum SGEF.b 130 to 550 149 to 569   capped   568/568
(100 %)
4 diff
(99.3 %id)
DA186142 amygdala SGEF.b 130 to 189 162 to 221   capped   220/220
(100 %)
3 diff
(98.7 %id)
DA248533 brain SGEF.b 130 to 559 161 to 590   capped   589/589
(100 %)
3 diff
(99.5 %id)
BG772682 testis SGEF.b 130 to 626 166 to 658       658/930
(70 %)
17 diff
(98.2 %id)
NM_015595.3   SGEF.b 130 to 5150 161 to 5181 exact RefSeq,   5181/5181
(100 %)
0 diff
(100 %id)
AY552599 brain SGEF.b 181 to 2796 1 to 2616 V29L L60S tiling clone,   2616/2616
(100 %)
3 diff
(99.9 %id)
DA310208 hippocampus SGEF.b 907 to 1466 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DN992852 brain, whole brain SGEF.b 999 to 1608 9 to 618       610/618
(98 %)
6 diff
(99.1 %id)
DA284928 corpus callosum SGEF.b 1021 to 1576 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA679405   SGEF.b 1273 to 1841 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
AK022884   SGEF.b 1383 to 3871 1 to 2489   available from FLJ,   2489/2489
(100 %)
4 diff
(99.9 %id)
AU128105   SGEF.b 1383 to 2044 2 to 670   capped   669/671
(99 %)
12 diff
(98.3 %id)
DA728418   SGEF.b 1388 to 2107 15 to 735   capped   721/724
(99 %)
5 diff
(99.4 %id)
BX503267 Liver SGEF.b 1505 to 1972 9 to 476       468/476
(98 %)
6 diff
(98.8 %id)
DA121708 cerebellum SGEF.b 1581 to 2138 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DB185598 liver, tumor tissue SGEF.b 1586 to 2156 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
BC016628 Prostate, adenocarcinoma. SGEF.b 1751 to 3871 1 to 2119   available from MGC, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 2119/2119
(100 %)
5 diff
(99.8 %id)
BG254954 adenocarcinoma, cell line, Prostate SGEF.b 1754 to 2365 1 to 610   available from MGC,   610/610
(100 %)
8 diff
(98.7 %id)
TI_1948103516   SGEF.b 1882 to 2435 116 to 674   AAA   559/1298
(43 %)
33 diff
(97.5 %id)
TI_1948103647   SGEF.b 1882 to 2511 125 to 756   fully sequenced,   632/756
(83 %)
8 diff
(99.0 %id)
TI_1948103930   SGEF.b 1882 to 2342 123 to 584   fully sequenced,   462/584
(79 %)
6 diff
(99.0 %id)
CV029752 mixed SGEF.b 1891 to 2570 1 to 678       678/681
(99 %)
5 diff
(99.3 %id)
TI_1948103792   SGEF.b 1891 to 2511 129 to 749   fully sequenced,   621/749
(82 %)
10 diff
(98.7 %id)
CU444805 epidermis SGEF.b 2058 to 2510 6 to 458       453/458
(98 %)
7 diff
(98.5 %id)
CU447910 epidermis SGEF.b 2058 to 2276 6 to 224       219/224
(97 %)
6 diff
(97.4 %id)
CU449599 epidermis SGEF.b 2058 to 2678 6 to 626       621/626
(99 %)
7 diff
(98.9 %id)
CU453833 epidermis SGEF.b 2058 to 2755 6 to 703       698/703
(99 %)
11 diff
(98.5 %id)
CU456643 epidermis SGEF.b 2058 to 2815 6 to 763       758/763
(99 %)
7 diff
(99.1 %id)
BF852433 lung_normal SGEF.b 2114 to 2625 39 to 553       515/553
(93 %)
21 diff
(96.3 %id)
AL117429 testis SGEF.b 2159 to 3871 1 to 1713   available from DKFZ, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 1713/1713
(100 %)
3 diff
(99.9 %id)
CA434700 lung, Lung Focal Fibrosis SGEF.b 2301 to 2802 17 to 518     Submitted on the opposite strand 502/502
(100 %)
0 diff
(100 %id)
TI_1948103931   SGEF.b 2312 to 2795 595 to 112   fully sequenced,   484/595
(81 %)
0 diff
(100 %id)
AW878101 ovary SGEF.b 2387 to 2541 12 to 167       156/167
(93 %)
6 diff
(96.5 %id)
TI_1948103648   SGEF.b 2450 to 2795 469 to 124   fully sequenced,   346/469
(73 %)
0 diff
(100 %id)
TI_1948103793   SGEF.b 2450 to 2795 469 to 124   fully sequenced,   346/469
(73 %)
0 diff
(100 %id)
CU454635 epidermis SGEF.b 2451 to 3164 727 to 14     Submitted on the opposite strand 714/727
(98 %)
2 diff
(99.8 %id)
AA029036 uterus SGEF.b 2549 to 2923 383 to 1       383/457
(83 %)
8 diff
(98.3 %id)
EC549375 Prostate SGEF.b 2629 to 2726 1 to 97       97/97
(100 %)
1 diff
(99.0 %id)
R18690 whole brain SGEF.b 2632 to 3085 1 to 463       463/468
(98 %)
15 diff
(96.8 %id)
BI597607 brain, hypothalamus SGEF.b 2706 to 3538 1 to 843       843/1099
(76 %)
33 diff
(97.0 %id)
BI603959 brain, hypothalamus SGEF.b 2706 to 3494 1 to 791       791/793
(99 %)
15 diff
(98.2 %id)
DB491459 hypothalamus SGEF.b 2711 to 3119 1 to 408       408/408
(100 %)
2 diff
(99.6 %id)
TI_45209533   SGEF.b 2711 to 3538 89 to 926   AAA   838/1169
(71 %)
29 diff
(97.6 %id)
TI_45210222   SGEF.b 2711 to 3494 92 to 877       786/879
(89 %)
11 diff
(98.8 %id)
BM987736 mixed SGEF.b 2717 to 2913 210 to 14   AAA   197/197
(100 %)
0 diff
(100 %id)
EC579844 Prostate SGEF.b 2746 to 2847 5 to 106       102/106
(96 %)
6 diff
(94.4 %id)
AA426209   SGEF.b 2752 to 3198 10 to 457       448/457
(98 %)
6 diff
(98.7 %id)
AA860087   SGEF.b 2756 to 3119 366 to 3       364/366
(99 %)
0 diff
(100 %id)
DA137186 alzheimer cortex SGEF.b 2813 to 3358 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
AW663096 pooled SGEF.b 2846 to 3119 278 to 4       275/278
(98 %)
0 diff
(100 %id)
FN120554 breast carcinoma SGEF.b 2872 to 2979 1 to 106       106/106
(100 %)
7 diff
(93.4 %id)
EC575122 Prostate SGEF.b 2949 to 3031 1 to 82       82/87
(94 %)
5 diff
(94.3 %id)
BE879255 large cell carcinoma, undifferentiated, lung SGEF.b 3080 to 3786 1 to 704       704/704
(100 %)
13 diff
(98.2 %id)
CD250483 Blood vessels - aorta, basilar and artery SGEF.b 3132 to 3867 1 to 753   AAA   753/760
(99 %)
31 diff
(96.0 %id)
W05287 lung SGEF.b 3187 to 3530 1 to 350       350/491
(71 %)
12 diff
(97.6 %id)
CD722304 eye, lacrimal gland SGEF.b 3228 to 3718 38 to 528       491/536
(91 %)
31 diff
(94.3 %id)
AI740900 pooled SGEF.b 3258 to 3786 1 to 530     Submitted on the opposite strand 530/530
(100 %)
5 diff
(99.1 %id)
FN139358 breast carcinoma SGEF.b 3266 to 3348 1 to 81       81/81
(100 %)
2 diff
(97.6 %id)
AL048852 testis SGEF.b 3297 to 3871 605 to 31   tiling clone, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 575/575
(100 %)
0 diff
(100 %id)
FN143640 breast carcinoma SGEF.b 3307 to 3431 1 to 122       122/122
(100 %)
4 diff
(96.8 %id)
AI888703 poorly differentiated adenocarcinoma withsignet ring cell features, stomach SGEF.b 3351 to 3873 523 to 1       523/523
(100 %)
2 diff
(99.7 %id)
AI042352 parathyroid gland, parathyroid tumor SGEF.b 3354 to 3878 525 to 1       525/525
(100 %)
4 diff
(99.3 %id)
DB324771   SGEF.b 3354 to 3871 518 to 1       518/518
(100 %)
2 diff
(99.7 %id)
EC545565 Prostate SGEF.b 3359 to 3491 1 to 134       134/134
(100 %)
7 diff
(94.8 %id)
EC502404 Prostate SGEF.b 3365 to 3491 7 to 129       123/129
(95 %)
6 diff
(95.4 %id)
DA430810 colon SGEF.b 3376 to 3873 2 to 499   capped   498/498
(100 %)
2 diff
(99.6 %id)
AU118383 whole embryo, mainly head SGEF.b 3376 to 4232 2 to 852   capped   851/853
(99 %)
23 diff
(97.4 %id)
AA609384   SGEF.b 3385 to 3877 493 to 1   tiling clone,   493/493
(100 %)
2 diff
(99.6 %id)
AU150420   SGEF.b 3385 to 3871 487 to 1       487/489
(99 %)
3 diff
(99.4 %id)
BQ023102 placenta SGEF.b 3426 to 3889 465 to 1       465/465
(100 %)
6 diff
(98.8 %id)
EC457231 Prostate SGEF.b 3449 to 3580 1 to 128   tiling clone,   128/128
(100 %)
8 diff
(93.8 %id)
AW103672 brain, tumor, 5 pooled (see description) SGEF.b 3453 to 3873 422 to 1       422/422
(100 %)
3 diff
(99.3 %id)
AA425141   SGEF.b 3476 to 3871 396 to 1       396/396
(100 %)
0 diff
(100 %id)
EC491173 Prostate SGEF.b 3537 to 3649 1 to 113       113/113
(100 %)
0 diff
(100 %id)
BU754524 placenta SGEF.b 3597 to 3889 293 to 1       293/293
(100 %)
2 diff
(99.4 %id)
BX502638 Liver SGEF.b 3604 to 4196 1 to 591       591/591
(100 %)
6 diff
(99.0 %id)
BX502615 Liver SGEF.b 3605 to 4181 1 to 575       575/575
(100 %)
2 diff
(99.7 %id)
F12050 brain, total brain SGEF.b 3607 to 3898 1 to 293       293/303
(96 %)
2 diff
(99.4 %id)
CX870707 embryonic stem SGEF.b 3624 to 4345 1 to 721       721/721
(100 %)
1 diff
(99.9 %id)
T66239 whole brain SGEF.b 3634 to 3872 1 to 237     Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 237/237
(100 %)
4 diff
(98.4 %id)
W96280 eye, retina SGEF.b 3728 to 3859 1 to 131       131/131
(100 %)
1 diff
(99.3 %id)
AV708562 adrenal gland SGEF.b 3865 to 4556 22 to 717       696/717
(97 %)
6 diff
(99.2 %id)
CB156439 brain SGEF.b 3874 to 4417 1 to 544   tiling clone,   544/544
(100 %)
1 diff
(99.9 %id)
CF147183 CNCAP(3)T-225 cell line, Prostate SGEF.b 3923 to 4631 8 to 716       709/716
(99 %)
6 diff
(99.2 %id)
TI_154179770   SGEF.b 3923 to 4763 74 to 912   tiling clone,   839/839
(100 %)
11 diff
(98.7 %id)
BM793807 Ascites, stomach SGEF.b 3925 to 4552 1 to 628       628/628
(100 %)
0 diff
(100 %id)
W35142 heart SGEF.b 3966 to 4295 1 to 335       335/335
(100 %)
6 diff
(98.3 %id)
BG180019 adenocarcinoma, cell line, Prostate SGEF.b 3987 to 4654 12 to 679       668/1024
(65 %)
5 diff
(99.6 %id)
CB047698 Kidney SGEF.b 4000 to 4548 4 to 552   fully sequenced, Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 549/552
(99 %)
5 diff
(99.1 %id)
BF858184 prostate_tumor SGEF.b 4003 to 4461 7 to 465       459/465
(98 %)
6 diff
(98.8 %id)
FN152119 breast carcinoma SGEF.b 4012 to 4083 1 to 73       73/74
(98 %)
3 diff
(96.0 %id)
CF139645 CNCAP(3)T-225 cell line, Prostate SGEF.b 4012 to 4401 8 to 397       390/397
(98 %)
6 diff
(98.5 %id)
CF140800 CNCAP(3)T-225 cell line, Prostate SGEF.b 4012 to 4300 8 to 297       290/297
(97 %)
9 diff
(97.0 %id)
TI_154169957   SGEF.b 4012 to 4538 80 to 610       531/615
(86 %)
20 diff
(96.8 %id)
BM729068 eye, fetal eye SGEF.b 4141 to 4593 1 to 453   fully sequenced, Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 453/453
(100 %)
0 diff
(100 %id)
AV724614 hypothalamus SGEF.b 4157 to 4577 1 to 412       412/413
(99 %)
8 diff
(98.1 %id)
CB047697 Kidney SGEF.b 4518 to 5144 661 to 35   tiling clone, fully sequenced, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 627/627
(100 %)
1 diff
(99.9 %id)
BM682002 eye, fetal eye SGEF.b 4563 to 5149 606 to 19   tiling clone, fully sequenced, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 588/588
(100 %)
1 diff
(99.9 %id)
W96189 eye, retina SGEF.b 4756 to 5144 389 to 1       389/389
(100 %)
0 diff
(100 %id)
T66162 whole brain SGEF.b 4847 to 5148 315 to 11   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 305/305
(100 %)
7 diff
(97.8 %id)
F09694 brain, total brain SGEF.b 4877 to 5148 273 to 1       273/273
(100 %)
3 diff
(99.0 %id)
W23622 heart SGEF.b 4906 to 5148 243 to 1       243/261
(93 %)
4 diff
(98.5 %id)
AK123040   SGEF.c 1 to 3780 2 to 3781 V29L L60S tiling clone, available from FLJ,   3781/3781
(100 %)
6 diff
(99.9 %id)
BG542831 lung SGEF.c 2293 to 2999 1 to 717       717/875
(81 %)
48 diff
(94.6 %id)
BX093031 whole brain SGEF.c 2337 to 2863 1 to 527   tiling clone,   527/527
(100 %)
2 diff
(99.7 %id)
R56723 whole brain SGEF.c 2338 to 2882 1 to 539       539/541
(99 %)
18 diff
(96.7 %id)
R56877 whole brain SGEF.c 3389 to 3783 411 to 11   tiling clone,   401/411
(97 %)
0 diff
(100 %id)
AB073386   SGEF.d 1 to 2353 1 to 2354 V29L L60P F203S tiling clone, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 2354/2354
(100 %)
5 diff
(99.8 %id)
N79370 multiple sclerosis lesions SGEF.d 1390 to 1723 1 to 342       342/343
(99 %)
11 diff
(96.8 %id)
AA195770 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SGEF.d 1469 to 1730 1 to 265       265/272
(97 %)
8 diff
(97.1 %id)
CB122093 Liver SGEF.d 1541 to 1934 1 to 394       394/394
(100 %)
0 diff
(100 %id)
BQ446856 Knee, Osteoarthritic Cartilage SGEF.d 1563 to 2349 803 to 17   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 787/787
(100 %)
3 diff
(99.7 %id)
H82685 liver and spleen SGEF.d 1735 to 2010 278 to 1     Submitted on the opposite strand 278/279
(99 %)
2 diff
(99.3 %id)
FN150656 breast carcinoma SGEF.d 1746 to 1844 98 to 1     Submitted on the opposite strand 98/98
(100 %)
1 diff
(99.0 %id)
AI989530 pooled germ cell tumors SGEF.d 1763 to 2354 596 to 4       593/596
(99 %)
0 diff
(100 %id)
AW235054 Kidney SGEF.d 1787 to 2353 570 to 3       568/570
(99 %)
0 diff
(100 %id)
CR742643 multiple sclerosis lesions SGEF.d 1821 to 2252 1 to 433       433/433
(100 %)
2 diff
(99.6 %id)
N98940 multiple sclerosis lesions SGEF.d 1821 to 2093 1 to 277   fully sequenced,   277/277
(100 %)
1 diff
(99.7 %id)
BF221677 Prostate SGEF.d 1831 to 2355 530 to 5       526/530
(99 %)
0 diff
(100 %id)
AI150361   SGEF.d 1846 to 2350 509 to 4       506/509
(99 %)
0 diff
(100 %id)
BF431051 pooled SGEF.d 1847 to 2349 515 to 11   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 505/505
(100 %)
2 diff
(99.7 %id)
BE768792 prostate_tumor SGEF.d 1854 to 2333 479 to 1       479/487
(98 %)
16 diff
(96.8 %id)
BE768789 prostate_tumor SGEF.d 1860 to 2340 480 to 2       479/480
(99 %)
0 diff
(100 %id)
AI580129 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SGEF.d 1862 to 2353 498 to 6       493/498
(98 %)
0 diff
(100 %id)
AI057555 parathyroid gland, parathyroid tumor SGEF.d 1875 to 2353 505 to 26   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 480/480
(100 %)
1 diff
(99.8 %id)
AW043796 pooled SGEF.d 1876 to 2353 501 to 23   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 479/479
(100 %)
3 diff
(99.4 %id)
AA364836 pineal body SGEF.d 1891 to 2179 1 to 289       289/289
(100 %)
0 diff
(100 %id)
AW953937   SGEF.d 1902 to 2353 1 to 453   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 453/453
(100 %)
1 diff
(99.8 %id)
DB520048 testis SGEF.d 1902 to 2350 1 to 451     Submitted on the opposite strand 451/460
(98 %)
4 diff
(99.2 %id)
AI149660   SGEF.d 1903 to 2350 452 to 4       449/452
(99 %)
0 diff
(100 %id)
AI341749   SGEF.d 1903 to 2349 459 to 12   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 448/448
(100 %)
2 diff
(99.6 %id)
AI278345 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SGEF.d 1905 to 2353 456 to 4       453/456
(99 %)
0 diff
(100 %id)
AI050702   SGEF.d 1906 to 2353 452 to 4       449/452
(99 %)
0 diff
(100 %id)
AW593811 pooled germ cell tumors SGEF.d 1908 to 2354 450 to 3       448/450
(99 %)
0 diff
(100 %id)
AA890400 parathyroid gland, parathyroid tumor SGEF.d 1909 to 2353 457 to 12   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 446/446
(100 %)
1 diff
(99.8 %id)
AI017789   SGEF.d 1910 to 2354 449 to 4       446/449
(99 %)
0 diff
(100 %id)
AI040854 parathyroid gland, parathyroid tumor SGEF.d 1910 to 2353 451 to 8       444/451
(98 %)
0 diff
(100 %id)
N62408 multiple sclerosis lesions SGEF.d 1922 to 2354 438 to 2       437/438
(99 %)
0 diff
(100 %id)
DB561969 hypothalamus SGEF.d 1928 to 2351 1 to 427     Submitted on the opposite strand 427/427
(100 %)
3 diff
(99.3 %id)
AW594715 pooled germ cell tumors SGEF.d 1945 to 2353 412 to 1       412/415
(99 %)
4 diff
(99.1 %id)
AI241724 brain, tumor, 5 pooled (see description) SGEF.d 1950 to 2353 404 to 1       404/405
(99 %)
2 diff
(99.6 %id)
AI422249 brain, glioblastoma (pooled) SGEF.d 1956 to 2353 399 to 1       399/399
(100 %)
2 diff
(99.5 %id)
BJ993605.
matches multiple genes
hepatoblastoma SGEF.d 1960 to 2312 354 to 1     also hits gene F2 354/354
(100 %)
1 diff
(99.8 %id)
AA195657 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SGEF.d 1965 to 2355 391 to 1   tiling clone,   391/391
(100 %)
1 diff
(99.8 %id)
AI088298 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SGEF.d 1979 to 2355 379 to 3       377/379
(99 %)
0 diff
(100 %id)
AV725197 hypothalamus SGEF.d 1987 to 2354 1 to 369   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 369/369
(100 %)
1 diff
(99.8 %id)
AA505277 breast SGEF.d 1997 to 2355 360 to 1       360/360
(100 %)
1 diff
(99.8 %id)
BE708807 head_neck SGEF.d 2005 to 2108 1 to 104       104/104
(100 %)
1 diff
(99.1 %id)
AA912890 pooled SGEF.d 2014 to 2354 346 to 5       342/346
(98 %)
0 diff
(100 %id)
FN168286 breast carcinoma SGEF.d 2049 to 2152 1 to 104       104/104
(100 %)
0 diff
(100 %id)
N66657 multiple sclerosis lesions SGEF.d 2063 to 2349 299 to 1   fully sequenced,   299/299
(100 %)
1 diff
(99.7 %id)
AI471190 brain, glioblastoma (pooled) SGEF.d 2159 to 2353 195 to 1       195/195
(100 %)
2 diff
(99.0 %id)
DB506816 testis SGEF.d 2170 to 2351 1 to 185     Submitted on the opposite strand 185/186
(99 %)
12 diff
(93.6 %id)
AF415176 prostate cancer SGEF.e 1 to 3106 1 to 3106 exact tiling clone,   3106/3106
(100 %)
5 diff
(99.9 %id)
BM725286 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid SGEF.f-u 1 to 212 22 to 233   tiling clone, fully sequenced,   212/233
(90 %)
3 diff
(98.8 %id)
BM677726 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid SGEF.f-u 182 to 625 449 to 1   tiling clone, fully sequenced,   449/449
(100 %)
3 diff
(99.4 %id)
DB092386 testis SGEF.g-u 1 to 561 2 to 565 V29L L60P tiling clone, capped   564/564
(100 %)
6 diff
(99.0 %id)
DB441895 testis SGEF.g-u 35 to 467 1 to 433   tiling clone,   433/433
(100 %)
4 diff
(99.1 %id)
DB291630 uterus SGEF.h-u 1 to 601 2 to 600 exact tiling clone, capped   599/599
(100 %)
2 diff
(99.7 %id)
AL048851 testis SGEF.i-u 1 to 544 1 to 542 exact tiling clone,   542/542
(100 %)
12 diff
(97.8 %id)
DA362485 subthalamic nucleus SGEF.j-u 1 to 529 2 to 530 L46S tiling clone, capped   529/529
(100 %)
1 diff
(99.9 %id)
CN294551 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 SGEF.j-u 39 to 421 1 to 383   tiling clone,   383/385
(99 %)
3 diff
(99.3 %id)
AK022655   Gene SGEF, variant not shown       available from FLJ, Suspected internal deletion, this clone was ignored    
AV684035 hepatocellular carcinoma Gene SGEF, variant not shown         Suspected internal deletion, this clone was ignored    
AU148961   Gene SGEF, variant not shown         Suspected internal deletion, this clone was ignored    
AU125271   Gene SGEF, variant not shown       capped Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g-u, .h-u, .i-u, .j-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC